T: 416-862-4836 email JulieView full profile.
T: 613-761-2424 email CharlesView full profile.
T: 416-862-4837 email RichardView full profile.
T: 416-646-4894 email GiselleView full profile.
T: 613-217-8521 email John View full profile.
T: 416-862-4825 email MatthewView full profile.
T: 416-862-4826 email JohnView full profile.
T: 416-862-4827 email Raeya View full profile.
T: 416-862-4820 email MarcView full profile.
T: 416-862-4831 email CarlView full profile.
T: 416-642-4874 email AlessiaView full profile.
T: 416-862-4822 email DonnaView full profile.
T: 416-862-4829 email AnandView full profile.
T: 416-862-4828 email JacquelynView full profile.
T: 416-862-4835 email MadihaView full profile.
T: 416-862-4830 email JoannaView full profile.
Environment • Aboriginal • Energy
Anyone wishing to nominate a substance to the Revised In Commerce List (“R-ICL”) must do so before November 3, 2019. On November 3, 2019, the nomination process ends and no further nominations will be accepted.
The R-ICL is a list of substances that were in Canadian commerce between January 1987 and September 2001 contained in products regulated under the Food and Drugs Act (“FDA”).
Any person in Canada involved with the manufacture, import, distribution, or use of an eligible substance may submit a nomination for a substance to the R-ICL until November 3, 2019. Foreign suppliers may also make nominations, provided that the nomination is made through a person resident in Canada and authorized to act on behalf of the foreign supplier.
Click here to read the full article.